ALZCHEM GROUP AG INH O.N.
ALZCHEM GROUP AG INH O.N./ DE000A2YNT30 /
ACT/D
13/11/2024 17:40:12
|
Diferencia
+2.0000
|
Volumen |
Bid20:45:46 |
Ask20:45:46 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
55.6000EUR
|
+3.73%
|
59 Volumen de negocios: 3,282.8000 |
56.2000Volumen de oferta: 100 |
56.6000Tamaño/ Volumen/ Formato de Ask: 100 |
565.8 millonesEUR |
1.89% |
16.35 |
Descripción de negocio
AlzChem AG, located in Trostberg, Bavaria, is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding, which are used in a variety of industries. The company has a leading market position in selected niche markets, including the markets for feed additives and food supplements. The strategic focus of growth and the focus of the extensive research and development lie on the business segment Specialty Chemicals. The joint production and the brand portfolio protect AlzChem from potential market entries.
Consejo de gestión & Consejo de supervisión
CEO |
Andreas Lösler |
Consejo de gestión |
Andreas Niedermaier, Klaus Englmaier, Dr. Georg Weichselbaumer |
Consejo de supervisión |
Markus Zöllner, Prof. Dr. Martina Heigl-Murauer, Steve Röper, Dr. Caspar Freiherr von Schnurbein |
Datos de la empresa
Nombre: |
AlzChem Group AG |
Dirección: |
Chemiepark Trostberg, Dr.-Albert-Frank-Str. 32,D-83308 Trostberg |
Teléfono: |
+49-8621-86-0 |
Fax: |
+49-8621-86-2911 |
E-mail: |
info@alzchem.com
|
Internet: |
https://www.alzchem.com/ |
Industria: |
Commodities |
Sector: |
Chemicals |
Subsector: |
Chemicals, diversified |
Fin del año financiero: |
31/12 |
Acciones de libre circulación: |
50.35% |
Fecha de OPI: |
01/06/1999 |
Relación con inversores
Nombre: |
Sabine Sieber |
IR teléfono: |
+49-8621-86-2888 |
IR-fax: |
- |
IR e-mail: |
ir@alzchem.com
|
Calendario de la empresa
CW 9 | 28/02/2025
4th Quarter/Annual Report
|
CW 18 | 30/04/2025
Interim Report 1st Quarter/3 Months
|
CW 31 | 30/07/2025
Interim Report 2nd Quarter/6 Months
|
CW 44 | 30/10/2025
Interim Report 3rd Quarter/9 Months
|